News

 

 

“Sundance Diagnostics Advises Faulty Genes should be Studied in the Death of Prince”

Read Article


 

Video: “Genetic Rx: Prescription Drugs Can be Lethal”

Watch Video


“Study: Most Antidepressants Don’t Work for Young Patients”

Read Article


“A Colorado provider is using a connected care platform to help teens and young adults – and their families – deal with adverse reactions to depression medications” mHealth Intelligence

Read Article


Decades after they were sold as “safe and effective” medicines, millions who were prescribed antidepressant, antipsychotic and other psychiatric drugs discovered their hidden perils. “Letters from Generation Rx” represents the stories of thousands of real people who experienced firsthand how the cavalier use of these powerful psychotropics created a new class of disability—and an avalanche of other devastating consequences.

Watch Trailer


Cafyne Announces Healthcare Edition – Platform Enables Precision Medicine Client, Sundance Diagnostics, to Meet Social Media Security and Regulatory Requirements

Read Article


“Suicidality and aggression during antidepressant treatment: systematic review and meta-analyses based on clinical study reports”  British Medical Journal Publication

Read Article


“Antidepressants can raise the risk of suicide, biggest ever review finds”  The Telegraph

Read Article


“Throw away the antidepressants, urges leading scientist”  The Telegraph

Read Article


 

Letters:

Suicidality and Aggression During Antidepressant Treatment “Authors reply to Dubicka and colleagues and Stone”  

Read 


 

Letters:

Antidepressants v Cognitive Behavioral Therapies  “Antidepressants are addictive and increase the risk of relapse”

Read 


 

“Searching Genes to Avoid Medical Side-Effects”  Wall Street Journal, Shirley Wang

Can patients’ DNA warn doctors against prescribing antidepressants, other drugs?

Read Article   


“Genetics May Bring Out the Dark Side of Antidepressants”  The Verge,  Russell Brandom

A new test uses genetic data to fight patients’ risk of drug-reactive suicide

Read Article 


Sundance Diagnostics and the Max Planck Institute of Psychiatry Agree on Global License for Commercialization

Read Article


Press Release, The Max Planck Institute “Suicidality test being brought to market”

U.S. company Sundance Diagnostics has licensed genetic markers that predict suicide risk when antidepressant drugs are prescribed

Read Article


“Sundance Diagnostics Developing Antidepressant Suicide Risk Test” Yahoo Finance

Sundance Diagnostics and the Max Planck Institute of Psychiatry Agree on Global License for Commercialization

Read Article